Cancer Research

Biophotonics in Pathology

read more...
Pub. date
April 2013
Editor
Cohen, S.
Volume
185 of Studies in Health Technology and Informatics
Price
US$130 / €99 / £85
ISBN print
978-1-61499-233-2
Subject
Cancer Research, Medicine & Health

Translational Pathology of Early Cancer

read more...
Pub. date
March 2012
Editors
Srivastava, S., Grizzle, W.E.
Price
US$239 / €156 / £140
ISBN print
978-1-61499-023-9
Subject
Cancer Research

Biomarkers for Ovarian Cancer: New Technologies and Targets to Address Persistently Unmet Needs

read more...
Pub. date
November 2011
Editors
Tainsky, M.A., Lokshin, A.
Price
US$167 / €115
ISBN print
978-1-60750-978-3
Subject
Cancer Research

Diagnostic and Prognostic Markers in Liver Cirrhosis

read more...
Pub. date
November 2011
Editors
Augustin, S., Genescà, J.
Price
US$131 / €90
ISBN print
978-1-60750-979-0
Subject
Cancer Research

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

read more...
Pub. date
November 2011
Editors
Eng-Wong, J., Zujewski, J.A.
Price
US$167 / €115
ISBN print
978-1-60750-977-6
Subject
Cancer Research

Molecular Biology of Post Traumatic Stress Disorder

read more...
Pub. date
April 2011
Editor
Yehuda, R.
Price
US$130 / €90
ISBN print
978-1-60750-748-2
Subject
Cancer Research, Medicine & Health

Metastasis Imaging: Current Concepts and Future Challenges

read more...
Pub. date
April 2011
Editors
Messiou, C., deSouza, N.M.
Price
US$116 / €80
ISBN print
978-1-60750-745-1
Subject
Cancer Research

Breast Disease

ISSN
0888-6008

Kidney Cancer

Kidney Cancer is an international multidisciplinary journal to facilitate progress in understanding…

read more...
ISSN print
2468-4562
Price
US$206 / €174
Volume
3; 4 issues
Subject
Cancer Research, Urology

Bladder Cancer

High-quality journal giving equal weight to original research in basic science, translational resear…

read more...
ISSN print
2352-3727
Price
US$570 / €475
Volume
5; 4 issues
Subject
Cancer Research, Urology

Cancer Biomarkers

Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original resea…

read more...
ISSN print
1574-0153
Price
US$1530 / €1210
Volume
24-25; 12 issues
Subject
Cancer Research, Medicine & Health

Human Antibodies

Human Antibodies is an international journal designed to bring together all aspects of human hybrido…

read more...
ISSN print
1093-2607
Price
US$785 / €605
Volume
27; 4 issues
Subject
Cancer Research, Medicine & Health

Breast Disease

The recent expansion of work in the field of breast cancer inevitably will hasten discoveries that w…

read more...
ISSN print
0888-6008
Price
US$595 / €470
Volume
38; 4 issues
Subject
Cancer Research, Medicine & Health

Top Cancer Clinician-Scientist Appointed Director of Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai

May 24, 2018 - Los Angeles, USA – Renowned cancer clinician and scientist Dan Theodorescu, MD, PhD, has been named director of the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai.

Use of Ibuprofen and Similar NSAIDs May Shorten Life of Patients with Metastatic Renal Cell Carcinoma

May 1, 2018 - Amsterdam, NL – Ibuprofen, aspirin, and other non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, NSAIDs’ promising anti-cancer properties have been highlighted by a growing body of data in recent years. However, a new study in the journal Kidney Cancer indicated that non-aspirin NSAID use was associated with shorter overall survival in patients with metastatic renal cell carcinoma (mRCC).

New Analysis Shows Hexvix®/Cysview® Significantly Prolongs Time To Progression Of Bladder Cancer

April 29, 2016 - Photocure ASA (OSE: PHO), is pleased to announce publication of a new analysis demonstrating that Blue Light Cystoscopy (BLC) with Hexvix/Cysview significantly prolonged time to disease progression and showed a trend in the reduction of the rate of progression in patients with non-muscle invasive bladder cancer (NMIBC). The data was published online in the April issue of the peer reviewed journal, Bladder Cancer.

Researchers Make Progress in Genomic Classification of Bladder Cancers

February 19, 2016 - The ability to map the human genome has transformed how scientists and researchers classify various cancers. In the past, cancer cells were examined through a microscope and their appearance, often enhanced with dyes or other agents, was used to categorize the type of cancer. Now, it is possible to extract the DNA or RNA from these cells and establish a classification according to the type and quantity of mutations, active and inactive genes, and other molecular characteristics. An article in the current issue of Bladder Cancer reports the results of a consensus meeting of experts in the field and describes the recent efforts to classify bladder cancers.

MicroRNAs Present Exciting Opportunities for Cancer Therapy and Diagnosis

December 20, 2012 - As many as 50 percent of all human protein-coding genes are regulated by microRNA (miRNA) molecules. While some miRNAs impact onset and progression of cancer, others can actually suppress the development of malignant tumors and are useful in cancer therapy. They can also serve as potential biomarkers for early cancer detection. In a new issue of Cancer Biomarkers, investigators report on non-coding miRNAs as appealing biomarkers for malignancy.

2013 Cancer Research Brochure

November 27, 2012 - View the new Cancer Research Brochure here.